Coagulopathies and Sickle Cell Disease
Document Type
Book Chapter
Publication Date
2026
Identifier
DOI: 10.1016/B978-0-443-12431-0.00004-8
Abstract
Hemostasis is the reaction of the body to endothelial damage of blood vessels to prevent bleeding. Primary hemostasis involves platelets, von Willebrand factor, collagen, and fibrinogen to form a platelet plug. Secondary hemostasis occurs as thrombin is generated to form a fibrin clot. The process is complex and multistep and must be tightly regulated to control bleeding. Pediatric patients should be appropriately screened for hemostatic disorders before surgery, and those with hemostatic disorders should be managed carefully in conjunction with a hematologist throughout the entire operative process. Sickle cell disease (SCD) is a multisystem disorder affecting more than 100,000 individuals in the United States. It results from variants in the β-globin chain of hemoglobin. Primary pathophysiology is due to anemia from polymerization that reduces red blood cell survival. Pediatric patients with SCD face unique and potentially life-threatening complications with surgical procedures and deep sedation and require appropriate preoperative, intraoperative, and postoperative management by a multidisciplinary team.
Journal Title
Holcomb and Ashcraft's Pediatric Surgery (Eighth Edition)
First Page
53
Last Page
65
Keywords
Acute chest syndrome; Avascular necrosis; Coagulation defects; Hemostasis; Hypoxia; Infiltration; Platelet disorder; Retinopathy; Sequestration; Sickle cell disease; Sickle cell pain; Splenic sequestration; Transfusion; von Willebrand disease
Recommended Citation
Amos LE, Carpenter SL. Coagulopathies and sickle cell disease. Holcomb and Ashcraft’s Pediatric Surgery. Published online 2026:53-65. doi:10.1016/b978-0-443-12431-0.00004-8

